Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03504397
Brief Title: A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer (Spotlight)

First Submitted : April 12, 2018
First Submitted that Met QC Criteria : April 12, 2018
First Posted : April 20, 2018

Last Update Submitted that Met QC Criteria : June 9, 2021
Last Update Posted : June 10, 2021